Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

for
Heart Failure, Congestive, Death, Sudden, Cardiac, Arrhythmia,
Location: Washington D.C. DC, Baltimore MD, Richmond VA
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT00733590

Recruiting

Coronary Microvascular Disease (CMD) Registry

for
Coronary Microvascular Dysfunction
Location: Washington DC, Clinton MD, Hollywood FL
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18+

Code: NCT05960474

Recruiting

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

for
Breast Cancer
Location: Annapolis MD, Hershey PA, Philadelphia PA, Norfolk VA,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07100106

Phase 1, Phase 2, Recruiting

FiberLocker® System Augmentation of Rotator Cuff Repairs

for
Rotator Cuff Tear, Rotator Cuff Tears,
Location: Columbia MD, Winston-Salem NC, Chicago IL, Medford OR
Sponsor: ZuriMED Technologies Inc.

Sex: All

Age: 30 - 70

Code: NCT06918041

Recruiting

Ocular Complications From Cancer Therapy - Patient Registry and Biobank

for
Graft Versus Host Disease in Eye, Ocular Complications,
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT06874283

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

for
Arrythmia, Cardiomyopathies
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT05034432

Recruiting

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

for
Hereditary Angioedema (HAE), Angioedema,
Location: Wheaton MD
Sponsor: Institute for Asthma and Allergy

Sex: All

Age: 18 - 70+

Code: NCT07046806

Phase 1, Phase 2, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Washington D.C. DC, Fairfax VA, Towson MD, Roanoke VA,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase 3, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Washington D.C. DC, Olney MD, Richmond VA, Teaneck NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase 3, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for
Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

for
Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis,
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Eidos Therapeutics, a BridgeBio company

Sex: All

Age: 18 - 70+

Code: NCT06563895

Phase 3, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Washington D.C. DC, Baltimore MD, Lancaster PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Washington D.C. DC, Columbia MD, Manassas VA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase 3, Recruiting

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase 3, Recruiting

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

for
COVID-19 Infection
Location: Rockville MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 0 - 70+

Code: NCT04582903

Recruiting

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

for
COVID-19 Infection
Location: Washington D.C. DC, Silver Spring MD, Baltimore MD,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07013474

Phase 3, Recruiting

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

for
Crohn's Disease, Ulcerative Colitis
Location: Glen Burnie MD, Tyler TX
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06764615

Phase 2, Recruiting

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

for
COVID-19 SARS-CoV-2 Infection
Location: Washington D.C. DC, Silver Spring MD, Columbia MD,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT06679140

Phase 3, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Baltimore MD, Lancaster PA, Bala-Cynwyd PA,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase 2, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

for
Alzheimer Disease
Location: Gaithersburg MD, Princeton NJ, Woodmere NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011732

Phase 3, Recruiting